DNMT3A and acute myeloid leukemia: DNMT3A, mutated in approximately 30% of NK-AML and encoding a DNA methyltransferase that catalyses 5-methylcytosine methylation, is another example of mutation affecting prognosis, being related to anthracycline resistance and PIF [22].